Cell Growth & Differentiation, Vol 8, Issue 4 443-449, Copyright © 1997 by American Association of Cancer Research

ARTICLES

Down-regulation of apurinic/apyrimidinic endonuclease expression is associated with the induction of apoptosis in differentiating myeloid leukemia cells

KA Robertson, DP Hill, Y Xu, L Liu, S Van Epps, DM Hockenbery, JR Park, TM Wilson and MR Kelley
Department of Pediatrics, Herman B. Wells Center for Pediatric Research, James Whitcomb Riley Hospital for Children, Indiana University Medical Center, Indianapolis 46202-5225, USA.

The human DNA repair enzyme apurinic/apyrimidinic endonuclease (APE/ref-1) is a multifunctional protein in the DNA base excision repair (BER) pathway that is responsible for repair of apurinic/apyrimidinic (AP) sites in DNA. DNA repair and programmed cell death both function using different mechanisms to protect the organism from the consequences of extensive cellular damage; however, little is known about the relationship of the DNA BER repair pathway to apoptosis. We have determined the relationship of a BER DNA repair enzyme, APE, to apoptosis using the myeloid leukemia cell line HL-60, which can be induced to differentiate down the granulocytic or monocytic/ macrophage pathway. Treatment of HL-60 cells with retinoic acid/DMSO (granulocytic) or phorbol 12-myristate 13-acetate (monocytic) results in apoptosis and in down-regulation of APE expression at both the RNA and protein levels. Moreover, double-labeling experiments using APE immunohistochemistry and the terminal deoxyribonucleotidyl transferase-mediated dUTP-fluorescein nick end labeling assay for apoptosis demonstrate that individual cells undergoing apoptosis lose expression of APE regardless of their state of differentiation. Blocking apoptosis by overexpression of the bcl-2 proto-oncogene in HL-60 cells or by a bcr-abl-related mechanism in K562 cells and subsequent differentiation results in morphological differentiation but no loss of APE expression. These studies establish that down-regulation of APE expression is associated with programmed cell death in cells of the myeloid lineage.

This article has been cited by other articles:

				A. Zaky, C. Busso, T. Izumi, R. Chattopadhyay, A. Bassiouny, S. Mitra, and K. K. Bhakat Regulation of the human AP-endonuclease (APE1/Ref-1) expression by the tumor suppressor p53 in response to DNA damage Nucleic Acids Res., March 1, 2008; 36(5): 1555 - 1566. [Abstract] [Full Text] [PDF]

				G.-M. Zou, M.-H. Luo, A. Reed, M. R. Kelley, and M. C. Yoder Ape1 regulates hematopoietic differentiation of embryonic stem cells through its redox functional domain Blood, March 1, 2007; 109(5): 1917 - 1922. [Abstract] [Full Text] [PDF]

				S. Yang, K. Irani, S. E. Heffron, F. Jurnak, and F. L. Meyskens Jr. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor Mol. Cancer Ther., December 1, 2005; 4(12): 1923 - 1935. [Abstract] [Full Text] [PDF]

				D. Wang, M. Luo, and M. R. Kelley Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: Enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition Mol. Cancer Ther., June 1, 2004; 3(6): 679 - 686. [Abstract] [Full Text] [PDF]

				J. Bartunek, M. Vanderheyden, M. W. M. Knaapen, W. Tack, M. M. Kockx, and M. Goethals Deoxyribonucleic acid damage/repairproteins are elevated in the failing human myocardium due to idiopathic dilated cardiomyopathy J. Am. Coll. Cardiol., September 18, 2002; 40(6): 1097 - 1103. [Abstract] [Full Text] [PDF]

				L. Liu, Y. Nakatsuru, and S. L. Gerson Base Excision Repair as a Therapeutic Target in Colon Cancer Clin. Cancer Res., September 1, 2002; 8(9): 2985 - 2991. [Abstract] [Full Text] [PDF]

				H. Fung, R. A. O. Bennett, and B. Demple Key Role of a Downstream Specificity Protein 1 Site in Cell Cycle-regulated Transcription of the AP Endonuclease Gene APE1/APEX in NIH3T3 Cells J. Biol. Chem., November 2, 2001; 276(45): 42011 - 42017. [Abstract] [Full Text] [PDF]

				M. R. Kelley, L. Cheng, R. Foster, R. Tritt, J. Jiang, J. Broshears, and M. Koch Elevated and Altered Expression of the Multifunctional DNA Base Excision Repair and Redox Enzyme Ape1/ref-1 in Prostate Cancer Clin. Cancer Res., April 1, 2001; 7(4): 824 - 830. [Abstract] [Full Text]

				K. A. Robertson, H. A. Bullock, Y. Xu, R. Tritt, E. Zimmerman, T. M. Ulbright, R. S. Foster, L. H. Einhorn, and M. R. Kelley Altered Expression of Ape1/ref-1 in Germ Cell Tumors and Overexpression in NT2 Cells Confers Resistance to Bleomycin and Radiation Cancer Res., March 1, 2001; 61(5): 2220 - 2225. [Abstract] [Full Text]

				L. B. CHIARINI and R. LINDEN Tissue Biology of Apoptosis: Ref-1 and Cell Differentiation in the Developing Retina Ann. N.Y. Acad. Sci., December 1, 2000; 926(1): 64 - 78. [Abstract] [Full Text] [PDF]

				G. Tell, A. Zecca, L. Pellizzari, P. Spessotto, A. Colombatti, M. R. Kelley, G. Damante, and C. Pucillo An environment to nucleus' signaling system operates in B lymphocytes: redox status modulates BSAP/Pax-5 activation through Ref-1 nuclear translocation Nucleic Acids Res., March 1, 2000; 28(5): 1099 - 1105. [Abstract] [Full Text] [PDF]

				D. H. Moore, H. Michael, R. Tritt, S. H. Parsons, and M. R. Kelley Alterations in the Expression of the DNA Repair/Redox Enzyme APE/ref-1 in Epithelial Ovarian Cancers Clin. Cancer Res., February 1, 2000; 6(2): 602 - 609. [Abstract] [Full Text]

				M. Fujimura, Y. Morita-Fujimura, P. Narasimhan, J.-C. Copin, M. Kawase, P. H. Chan, and C. Y. Hsu Copper-Zinc Superoxide Dismutase Prevents the Early Decrease of Apurinic/Apyrimidinic Endonuclease and Subsequent DNA Fragmentation After Transient Focal Cerebral Ischemia in Mice • Editorial Comment Stroke, November 1, 1999; 30(11): 2408 - 2415. [Abstract] [Full Text] [PDF]

				L. Liu, P. Taverna, C. M. Whitacre, S. Chatterjee, and S. L. Gerson Pharmacologic Disruption of Base Excision Repair Sensitizes Mismatch Repair-deficient and -proficient Colon Cancer Cells to Methylating Agents Clin. Cancer Res., October 1, 1999; 5(10): 2908 - 2917. [Abstract] [Full Text] [PDF]

				M. M. Monick, A. B. Carter, and G. W. Hunninghake Human Alveolar Macrophages Are Markedly Deficient in REF-1 and AP-1 DNA Binding Activity J. Biol. Chem., June 18, 1999; 274(25): 18075 - 18080. [Abstract] [Full Text] [PDF]

				M. Kawase, M. Fujimura, Y. Morita-Fujimura, P. H. Chan, and C. Iadecola Reduction of Apurinic/Apyrimidinic Endonuclease Expression After Transient Global Cerebral Ischemia in Rats : Implication of the Failure of DNA Repair in Neuronal Apoptosis • Editorial Comment: Implication of the Failure of DNA Repair in Neuronal Apoptosis Stroke, February 1, 1999; 30(2): 441 - 449. [Abstract] [Full Text] [PDF]

				J. Domen, K. L. Gandy, and I. L. Weissman Systemic Overexpression of BCL-2 in the Hematopoietic System Protects Transgenic Mice From the Consequences of Lethal Irradiation Blood, April 1, 1998; 91(7): 2272 - 2282. [Abstract] [Full Text] [PDF]

				W. K. Hansen, W. A. Deutsch, A. Yacoub, Y. Xu, D. A. Williams, and M. R. Kelley Creation of a Fully Functional Human Chimeric DNA Repair Protein. COMBINING O6-METHYLGUANINE DNA METHYLTRANSFERASE (MGMT) AND AP ENDONUCLEASE (APE/REDOX EFFECTOR FACTOR 1 (Ref 1)) DNA REPAIR PROTEINS J. Biol. Chem., January 9, 1998; 273(2): 756 - 762. [Abstract] [Full Text] [PDF]

				D. Daily, A. Vlamis-Gardikas, D. Offen, L. Mittelman, E. Melamed, A. Holmgren, and A. Barzilai Glutaredoxin Protects Cerebellar Granule Neurons from Dopamine-induced Apoptosis by Activating NF-kappa B via Ref-1 J. Biol. Chem., January 5, 2001; 276(2): 1335 - 1344. [Abstract] [Full Text] [PDF]